• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Impact of incretin-related agents on endothelial cell function

    2017-04-09 08:18:33HiroshiNomotoHideakiMiyoshiAkinobuNakamuraTatsuyaAtsumiNaokiMandaYoshioKuriharaShinAokionbehalfofSAISStudyGroup

    Hiroshi Nomoto, Hideaki Miyoshi, *, Akinobu Nakamura, Tatsuya Atsumi, Naoki Manda, Yoshio Kurihara,Shin Aoki, on behalf of SAIS Study Group^

    1 Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    2 Manda Memorial Hospital, Sapporo, Japan

    3 Kurihara Clinic, Sapporo, Japan

    4 Aoki Clinic, Sapporo, Japan

    INTRODUCTION

    Prevention of atherosclerotic diseases, such as cardiovascular disease (CVD) and stroke is an issue that should be resolved in patients with type 2 diabetes mellitus because they have a higher risk of these conditions.1 Recent comprehensive care of patients with risk factors dramatically decreased diabetic macro- and microvascular complications,2but the mortality rate is still higher in populations with diabetes.3Therefore, detection and management of the earlier phases of atherosclerosis is important. It has been reported that endothelial cell damage precedes progressive atherosclerosis and these dysfunctions are known to be individual risk factors for CVD in type 2 diabetes mellitus.4,5For the relationship between therapeutics and endothelial cell function, numerous studies have been performed, and statins6and angiotensin II receptor blockers7 along with some anti-diabetic agents were reported to improve endothelial dysfunction.8,9

    In recent years, incretin-related drugs such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1(GLP-1) analogues, have been available to treat patients with type 2 diabetes mellitus and their anti-atherosclerotic potentials had been expected based on many in vitro studies and animal models. However, some longitudinal studies failed to verify their superiority for the prevention of CVD.10-12Moreover, their effects on endothelial cell function have been inconsistent.13We performed two different randomized controlled trials that focused on endothelial cell function, using different incretin-related agents, the DPP-4 inhibitor sitagliptin and the GLP-1 receptor agonist liraglutide. Results of these clinical trials demonstrated that both medications did not improve endothelial cell function assessed by flow-mediated dilatation. Here, we will introduce them and discuss the effects of incretin-related therapy on the early phase of atherosclerosis.

    THE EFFECT OF INCRETIN-RELATED THERAPY ON ENDOTHELIAL CELL FUNCTION

    We investigated whether incretin-related drugs improve endothelial cell function using flow-mediated dilatation(FMD) of the brachial artery. FMD is known to be a less-invasive tool that reflects endothelial nitric oxide bioavailability to evaluate endothelial cell function, and a reversible marker of early phase of atherosclerosis.14Additionally, a recent meta-analysis showed that improvement of FMD was significantly related to the relative risk reduction in cardiovascular events.15Thus, treatments that have favorable effects on FMD might be ideal for prevention form cardiovascular outcomes. We conducted two open-label, multicenter, prospective randomized parallel-group comparison studies comparing sitagliptin versus glimepiride (SAIS-1)16and liraglutide versus insulin glargine (SAIS-2)17(Table 1). Briefly, patients with type 2 diabetes mellitus who did not have severe atherosclerotic diseases were randomly assigned to each treatment, and underwent treatment for 26 or 14 weeks, respectively.FMD and biochemical assessment were performed before and after the treatment periods, and all FMD measurements were conducted under controlled conditions by a well-trained technician who was blinded to the study to minimize the introduction of potential confounding variables. For FMD, neither sitagliptin nor liraglutide affected endothelial cell function in this treatment periods,and neither did glimepiride and glargine (Table 2). Some previous clinical trials suggested that GLP-1 analogues and DPP-4 inhibitors improved FMD,18-20but there is some controversy including the lack of a control group,the study duration, the subject populations, and FMD measurement accuracy. Assessment of FMD is so sensitive that the results were greatly affected by many internal and environmental factors, such as patients’ background (sex,age, obesity, heart rate and smoking),21conditions (air temperature, mental/physical stress),22-24and the medications described above. There were opposing results and opinions about the relationship between incretin agents and FMD results.25,26Our studies fully controlled these confounding factors and both treatment groups were similarly controlled for glycemic metabolism. Moreover,another assessment method for endothelial dysfunction,End-PAT, also showed the same results. A recent metaanalysis revealed that efficacy of GLP-1-based therapies on FMD was confirmed only in cross-sectional studies but not in longitudinal studies.13It was reported that native GLP-1 infusion for several hours to individuals with type 2 diabetes resulted in improvement in endothelial function.27,28Although both GLP-1 and cleaved GLP-1,such as GLP-1(9–36) and GLP-1(28-36), may cause these effects, a study comparing the effect of native GLP-1 on vascular function with or without of sitagliptin to prevent an increase of the cleaved form of GLP-1 resulted in no detectable changes in both groups.29Although the existence of the GLP-1 receptor on the vascular endothelium has been suggested, recent accumulating evidence showed that the endothelium does not possess the GLP-1 receptor,30,31but there is currently no consensus. Thus, beneficial effects of incretin-related therapy on atherosclerotic changes may be mainly explained by indirect mechanisms rather than by direct action on endothelial cells.

    EFFECTS ON BETA-CELL FUNCTION AND ATHEROSCLEROSIS

    Incretin-related agents exert glucose-lowering effects in a blood glucose-dependent manner,32and they also play an important role in avoiding hypoglycemia by diminishing insulin secretion and preventing glucagon secretion under normal-to-hypoglycemic conditions.33Numerous in vitro and animal model experiments verified protective and proliferative effects of incretin-related agents on pancreatic beta-cells, and our prospective studies also demonstrated that both a DPP-4 inhibitor and a GLP-1 analogue showed incremental beta-cell functions, assessed by surrogate markers of insulin secretion (Table 2). Similarly, some clinical trials using incretin agents clarified incremental beta-cell function.34,35Effects of a GLP-1 analogue on beta-cell signaling include activating adenylate cyclase/protein kinase A, phosphatidylinositol 3-kinase/Akt, and the adenosine monophosphate kinase/mTOR cascades, which results in proliferation of beta-cells in rodents. However, the precise signaling of GLP-1 analogues has not been fully determined in humans.36Additionally, pancreatic beta-cells are known to be sensitive to oxidative stresses that result from relatively low expression levels of anti-oxidant enzymes, suchas superoxide dismutase, catalase, and glutathione peroxidase.37GLP-1 exerts anti-oxidant effects via suppression of nitric acid synthase expression in pancreatic beta-cells.38DPP-4 inhibitors were reported to reduce apoptosis in pancreatic beta-cells39,40and induce anti-oxidant responses,41and such mechanisms might be beneficial for protection of beta-cells from some kinds of stresses.

    Table 1: Inclusion criteria and outline of the original studies

    Table 2: Summary of the original studies

    In addition, long-term administration of these agents showed favorable effects on anti-oxidant, anti-atherosclerotic, and lipid metabolism in our study. One of the DPP-4 inhibitors, sitagliptin, ameliorated HDL-cholesterol via increasing adiponectin, anti-oxidant responses, and serum TNF-α levels. However, the GLP-1 analogue, liraglutide,caused a reduction of oxidative stress and improvement in cardiac load and atherosclerosis (Table 2). Incretinrelated drugs including DPP-4 inhibitors have been shown to have favorable effects on atherosclerosis via mediating several pathways, attenuating TNF-α-mediated induction of plasminogen activator inhibitor-1 expression,42preventing reactive oxygen species-induced cell senescence in endothelial cell lines,43increasing serum adiponectin levels,44suppressing macrophage-related inflammation, and inhibiting DPP-4-induced smooth muscle proliferation.45.

    Despite these many favorable mechanisms, many clinical trials using DPP-4 inhibitors failed to show their superiority to placebo in CVD outcomes.10-12One of the possible reasons is that these trials mainly included patients with atherosclerotic diseases. Therefore, even such potent agents may not be enough to suppress advanced atherosclerotic diseases. Earlier intervention may be beneficial for patients with early-phase atherosclerosis.

    CONCLUSIONS

    Accumulating evidence suggests that incretin-based therapy has anti-atherosclerotic effects and favorable effects on pancreatic beta-cells. However, the long-term results on endothelial cell function have not yet been determined. Our clinical trials provided direct evidence that these agents did not improve endothelial cell function in patients with type 2 diabetes, although their favorable effects on beta-cells and atherosclerosis are expected and will be assessed in the future.

    Conflicts of interest

    Author contributions

    HN and HM designed the original study. HN contributed to the writing the manuscript. HM and TA revised the manuscript. All authors contributed to enrollment of patients and approved the final manuscript.

    Plagiarism check

    This paper was screened twice using CrossCheck to verify originality before publication.

    Peer review

    This paper was double-blinded and stringently reviewed by international expert reviewers.

    1. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet.2010;375:2215-2222.

    2. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med.2014;370:1514-1523.

    3. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56:2601-2608.

    4. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA.2002;287:2570-2581.

    5. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev. 2001;22:36-52.

    6. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T.Low-density lipoprotein-independent improvement of flowmediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. Int J Cardiol.2012;158:285-289.

    7. Li S, Wu Y, Yu G, Xia Q, Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One. 2014;9:e90217.

    8. Papathanassiou K, Naka KK, Kazakos N, et al. Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis.2009;205:221-226.

    9. Wascher TC, Schmoelzer I, Wiegratz A, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. Eur J Clin Invest. 2005;35:551-557.

    10. Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med.2015;373:232-242.

    11. White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369:1327-1335.

    12. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.N Engl J Med. 2013;369:1317-1326.

    13. Song X, Jia H, Jiang Y, et al. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 diabetes Mellitus: a meta-analysis. Sci Rep.2015;5:10202.

    14. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation.2007;115:1285-1295.

    15. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631-640.

    16. Nomoto H, Miyoshi H, Furumoto T, et al. A randomized controlled trial comparing the effects of sitagliptin and glimepiride on endothelial function and metabolic parameters: Sapporo athero-incretin study 1 (SAIS1). PLoS One.2016;11:e0164255.

    17. Nomoto H, Miyoshi H, Furumoto T, et al. A comparison of the effects of the GLP-1 analogue liraglutide and insulin glargine on endothelial function and metabolic parameters: a randomized, controlled trial Sapporo athero-incretin study 2 (SAIS2).PLoS One. 2015;10:e0135854.

    18. Kubota Y, Miyamoto M, Takagi G, et al. The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes. J Korean Med Sci. 2012;27:1364-1370.

    19. Noda Y, Miyoshi T, Oe H, et al. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: a preliminary report. Cardiovasc Diabetol.2013;12:8.

    20. Irace C, De Luca S, Shehaj E, et al. Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research. Diab Vasc Dis Res. 2013;10:72-77.

    21. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community:the Framingham Heart Study. Circulation. 2004;109:613-619.

    22. Iwata M, Miyashita Y, Kumagai H. Seasonal variation of endothelium-dependent flow-mediated vasodilation measured in the same subjects. Am J Cardiovasc Dis. 2012;2:111-115.

    23. Amir O, Alroy S, Schliamser JE, et al. Brachial artery endothelial function in residents and fellows working night shifts. Am J Cardiol. 2004;93:947-949.

    24. Spieker LE, Hurlimann D, Ruschitzka F, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002;105:2817-2820.

    25. Ayaori M, Iwakami N, Uto-Kondo H, et al. Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J Am Heart Assoc. 2013;2:e003277.

    26. Hopkins ND, Cuthbertson DJ, Kemp GJ, et al. Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients. Diabetes Obes Metab. 2013;15:770-773.

    27. Ceriello A, Novials A, Canivell S, et al. Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory,antiinflammatory, and antioxidant action in type 2 diabetes.Diabetes Care. 2014;37:1938-1943.

    28. Nystrom T, Gutniak MK, Zhang Q, et al. Effects of glucagonlike peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab. 2004;287:E1209-1215.

    29. Devin JK, Pretorius M, Nian H, Yu C, Billings FTt, Brown NJ.Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm. J Am Heart Assoc. 2014;3.

    30. Pyke C, Knudsen LB. The glucagon-like peptide-1 receptor--or not? Endocrinology. 2013;154:4-8.

    31. Richards P, Parker HE, Adriaenssens AE, et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes. 2014;63:1224-1233.

    32. Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes.2013;62:3316-3323.

    33. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulindependent) diabetic patients. Diabetologia. 1993;36:741-744.

    34. Retnakaran R, Kramer CK, Choi H, Swaminathan B, Zinman B.Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care.2014;37:3270-3278.

    35. Leibowitz G, Cahn A, Bhatt DL, et al. Impact of treatment with saxagliptin on glycaemic stability and beta-cell function in the SAVOR-TIMI 53 study. Diabetes Obes Metab. 2015;17:487-494.

    36. Tuduri E, Lopez M, Dieguez C, Nadal A, Nogueiras R. Glucagon-like peptide 1 analogs and their effects on pancreatic islets.Trends Endocrinol Metab. 2016;27:304-318.

    37. Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.Biochem J. 1981;199:393-398.

    38. Jimenez-Feltstrom J, Lundquist I, Salehi A. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell Tissue Res. 2005;319:221-230.

    39. Mu J, Woods J, Zhou YP, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic betacell mass and function in a rodent model of type 2 diabetes.Diabetes. 2006;55:1695-1704.

    40. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes. 2008;57:1331-1339.

    41. Shah P, Ardestani A, Dharmadhikari G, et al. The DPP-4 inhibitor linagliptin restores beta-cell function and survival in human isolated islets through GLP-1 stabilization. J Clin Endocrinol Metab. 2013;98:E1163-1172.

    42. Liu H, Hu Y, Simpson RW, Dear AE. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression. J Endocrinol. 2008;196:57-65.

    43. Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells. Horm Metab Res. 2011;43:731-734.

    44. Hibuse T, Maeda N, Kishida K, et al. A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus--a randomized controlled trial START-J study. Cardiovasc Diabetol. 2014;13:96.

    45. Ervinna N, Mita T, Yasunari E, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154:1260-1270.

    国产伦精品一区二区三区四那| 三级国产精品欧美在线观看 | 99在线视频只有这里精品首页| 少妇的丰满在线观看| 真人做人爱边吃奶动态| 黄色 视频免费看| 色综合亚洲欧美另类图片| 最近视频中文字幕2019在线8| 又大又爽又粗| 久久精品aⅴ一区二区三区四区| 色尼玛亚洲综合影院| 亚洲成人久久爱视频| 日本撒尿小便嘘嘘汇集6| 俺也久久电影网| 又大又爽又粗| 母亲3免费完整高清在线观看| www.www免费av| 天天躁日日操中文字幕| 老鸭窝网址在线观看| 男女视频在线观看网站免费| 亚洲七黄色美女视频| 一个人免费在线观看电影 | 日本在线视频免费播放| 久久伊人香网站| 欧美大码av| 国产探花在线观看一区二区| 人人妻人人看人人澡| 亚洲成人久久性| 久久中文看片网| 亚洲五月天丁香| 亚洲国产中文字幕在线视频| 网址你懂的国产日韩在线| 97人妻精品一区二区三区麻豆| 琪琪午夜伦伦电影理论片6080| 毛片女人毛片| 中文字幕久久专区| 国内揄拍国产精品人妻在线| 岛国在线免费视频观看| 色综合欧美亚洲国产小说| 在线观看舔阴道视频| 日韩免费av在线播放| 两人在一起打扑克的视频| 少妇的逼水好多| 国内少妇人妻偷人精品xxx网站 | 欧美激情久久久久久爽电影| 一区福利在线观看| 99riav亚洲国产免费| 成人18禁在线播放| 黄色成人免费大全| 宅男免费午夜| 一级作爱视频免费观看| 9191精品国产免费久久| 成人三级黄色视频| 免费人成视频x8x8入口观看| 中文在线观看免费www的网站| 又紧又爽又黄一区二区| av欧美777| 最近最新中文字幕大全免费视频| 色尼玛亚洲综合影院| 麻豆成人av在线观看| 热99在线观看视频| 亚洲精品久久国产高清桃花| 久久香蕉国产精品| 一级作爱视频免费观看| 窝窝影院91人妻| 男人舔女人的私密视频| 黄频高清免费视频| www.熟女人妻精品国产| 国内精品美女久久久久久| 国产成年人精品一区二区| 美女cb高潮喷水在线观看 | 噜噜噜噜噜久久久久久91| 99久久国产精品久久久| 欧美日韩国产亚洲二区| 少妇人妻一区二区三区视频| 亚洲精华国产精华精| 亚洲第一电影网av| 国产精品久久久久久久电影 | 国产精华一区二区三区| 久久久久久九九精品二区国产| 天堂√8在线中文| 在线观看日韩欧美| 国产亚洲精品一区二区www| 精品人妻1区二区| 在线观看美女被高潮喷水网站 | а√天堂www在线а√下载| 国产成人欧美在线观看| 国产黄片美女视频| 美女高潮喷水抽搐中文字幕| 操出白浆在线播放| 国产熟女xx| av天堂在线播放| 久久久精品欧美日韩精品| 操出白浆在线播放| 岛国在线观看网站| 欧美午夜高清在线| 操出白浆在线播放| 久久久久国产精品人妻aⅴ院| 精品国产三级普通话版| 亚洲成av人片免费观看| 黑人操中国人逼视频| 男女午夜视频在线观看| 久久久久国产一级毛片高清牌| 国产探花在线观看一区二区| 国产三级在线视频| 欧美黑人巨大hd| av黄色大香蕉| 亚洲 国产 在线| 黄色视频,在线免费观看| 国产精品亚洲av一区麻豆| 国产免费男女视频| 日韩 欧美 亚洲 中文字幕| 一个人观看的视频www高清免费观看 | 制服人妻中文乱码| www.自偷自拍.com| 在线观看美女被高潮喷水网站 | 亚洲精华国产精华精| 观看免费一级毛片| 欧美日本亚洲视频在线播放| 亚洲精华国产精华精| 日本一本二区三区精品| 日韩免费av在线播放| 欧美性猛交╳xxx乱大交人| 欧美一级毛片孕妇| 精品一区二区三区视频在线观看免费| 亚洲av成人av| 亚洲人成伊人成综合网2020| 国产乱人伦免费视频| 国产欧美日韩一区二区三| 欧美成狂野欧美在线观看| 国产伦精品一区二区三区四那| 男女午夜视频在线观看| 欧美xxxx黑人xx丫x性爽| 国产aⅴ精品一区二区三区波| 国产一区二区三区视频了| 午夜福利免费观看在线| 亚洲国产精品久久男人天堂| 日本黄色视频三级网站网址| 露出奶头的视频| 91麻豆av在线| 老司机在亚洲福利影院| 巨乳人妻的诱惑在线观看| 亚洲精品国产精品久久久不卡| 一个人免费在线观看电影 | 嫩草影视91久久| 法律面前人人平等表现在哪些方面| 精品无人区乱码1区二区| 麻豆一二三区av精品| 亚洲自拍偷在线| 精品久久久久久久末码| 啦啦啦韩国在线观看视频| 大型黄色视频在线免费观看| 性色av乱码一区二区三区2| 99热这里只有精品一区 | 国产高清有码在线观看视频| 精品一区二区三区av网在线观看| 人人妻人人澡欧美一区二区| 国产精品久久视频播放| 怎么达到女性高潮| 最好的美女福利视频网| 久久天躁狠狠躁夜夜2o2o| 欧美最黄视频在线播放免费| 美女午夜性视频免费| 性色avwww在线观看| 窝窝影院91人妻| 亚洲欧美日韩无卡精品| 成年人黄色毛片网站| 亚洲av片天天在线观看| av欧美777| 精品欧美国产一区二区三| 日韩欧美在线乱码| 一区福利在线观看| 精品一区二区三区四区五区乱码| 一个人看的www免费观看视频| 亚洲av美国av| 久久久国产成人精品二区| 亚洲欧美精品综合一区二区三区| 久久香蕉国产精品| 91麻豆av在线| 欧美+亚洲+日韩+国产| 亚洲欧美日韩卡通动漫| 91老司机精品| 精品国产三级普通话版| 国内精品久久久久久久电影| 国语自产精品视频在线第100页| 亚洲精品色激情综合| 免费在线观看成人毛片| 国产黄片美女视频| 亚洲九九香蕉| 两个人看的免费小视频| 亚洲真实伦在线观看| 国产精品 国内视频| 怎么达到女性高潮| 久久久成人免费电影| 99久久国产精品久久久| 亚洲电影在线观看av| 亚洲av电影在线进入| 国产激情久久老熟女| 999久久久精品免费观看国产| 精品久久久久久久毛片微露脸| 美女扒开内裤让男人捅视频| 99久久久亚洲精品蜜臀av| 国产黄色小视频在线观看| 级片在线观看| 亚洲国产精品sss在线观看| 日本一二三区视频观看| 欧美精品啪啪一区二区三区| 成年女人永久免费观看视频| av黄色大香蕉| 国产男靠女视频免费网站| 18美女黄网站色大片免费观看| 99国产精品99久久久久| 国产主播在线观看一区二区| 成人鲁丝片一二三区免费| 九九在线视频观看精品| 日本a在线网址| 精品久久久久久久久久免费视频| 午夜福利18| 又大又爽又粗| 一a级毛片在线观看| 久久久久久国产a免费观看| 亚洲精品456在线播放app | 欧美丝袜亚洲另类 | 最近视频中文字幕2019在线8| 亚洲电影在线观看av| 少妇裸体淫交视频免费看高清| 日本一本二区三区精品| 啦啦啦免费观看视频1| 青草久久国产| 无限看片的www在线观看| 深夜精品福利| 99久国产av精品| 一区二区三区高清视频在线| 日本在线视频免费播放| 国产三级中文精品| 免费看十八禁软件| 亚洲午夜理论影院| 1024香蕉在线观看| 欧美极品一区二区三区四区| 久久久久久九九精品二区国产| 男女视频在线观看网站免费| 99国产精品一区二区三区| 国产私拍福利视频在线观看| 久久精品91蜜桃| 亚洲av电影不卡..在线观看| 又黄又爽又免费观看的视频| 国产一区在线观看成人免费| 午夜亚洲福利在线播放| 欧美日韩福利视频一区二区| 久久久精品大字幕| 韩国av一区二区三区四区| av在线蜜桃| 国产主播在线观看一区二区| 日本a在线网址| 欧美一级毛片孕妇| 香蕉久久夜色| 成人国产一区最新在线观看| 亚洲国产欧洲综合997久久,| www.www免费av| 黄色丝袜av网址大全| 日韩精品中文字幕看吧| 在线视频色国产色| 露出奶头的视频| 99久久久亚洲精品蜜臀av| 搡老岳熟女国产| 国产91精品成人一区二区三区| 久久香蕉国产精品| 美女 人体艺术 gogo| 麻豆一二三区av精品| 99国产极品粉嫩在线观看| 露出奶头的视频| 精品99又大又爽又粗少妇毛片 | 毛片女人毛片| www.熟女人妻精品国产| 美女cb高潮喷水在线观看 | 久久亚洲精品不卡| 欧美乱妇无乱码| 中文字幕高清在线视频| 午夜福利在线观看免费完整高清在 | 国产三级在线视频| 午夜激情福利司机影院| 悠悠久久av| 日韩高清综合在线| 国产精品99久久99久久久不卡| 国内毛片毛片毛片毛片毛片| 国产探花在线观看一区二区| 1024香蕉在线观看| 级片在线观看| 国产不卡一卡二| 两人在一起打扑克的视频| 久久久久久人人人人人| 久久久色成人| 精品国产亚洲在线| 18禁裸乳无遮挡免费网站照片| 岛国在线观看网站| 免费看美女性在线毛片视频| 中文资源天堂在线| 九色成人免费人妻av| 国产 一区 欧美 日韩| 日韩 欧美 亚洲 中文字幕| 97超级碰碰碰精品色视频在线观看| 99久久久亚洲精品蜜臀av| 高清毛片免费观看视频网站| 国产精品久久电影中文字幕| 99国产极品粉嫩在线观看| 精品熟女少妇八av免费久了| 午夜视频精品福利| 好男人在线观看高清免费视频| 免费av不卡在线播放| 国产黄色小视频在线观看| 亚洲av片天天在线观看| 亚洲av电影在线进入| 午夜福利高清视频| 国产真实乱freesex| 九九在线视频观看精品| 一本久久中文字幕| 白带黄色成豆腐渣| 搡老岳熟女国产| 国产成人一区二区三区免费视频网站| 国产爱豆传媒在线观看| 女警被强在线播放| 久久久久精品国产欧美久久久| 成人三级黄色视频| 亚洲中文字幕日韩| 中亚洲国语对白在线视频| 欧美日韩瑟瑟在线播放| 国产成人精品久久二区二区91| 亚洲一区二区三区不卡视频| 国产精品精品国产色婷婷| 小蜜桃在线观看免费完整版高清| 视频区欧美日本亚洲| 亚洲欧美日韩高清在线视频| 黄片小视频在线播放| 国产成人啪精品午夜网站| 巨乳人妻的诱惑在线观看| 又爽又黄无遮挡网站| 男人舔奶头视频| 国产真实乱freesex| 日本黄大片高清| 性色avwww在线观看| av天堂中文字幕网| 高清毛片免费观看视频网站| 亚洲精品色激情综合| 午夜久久久久精精品| 亚洲片人在线观看| 国产精品 欧美亚洲| 18禁黄网站禁片免费观看直播| 两人在一起打扑克的视频| 亚洲精品在线观看二区| 三级毛片av免费| 天堂动漫精品| 亚洲欧美日韩高清在线视频| 九色成人免费人妻av| 人妻丰满熟妇av一区二区三区| 美女黄网站色视频| 精品国产乱子伦一区二区三区| 美女高潮喷水抽搐中文字幕| 看免费av毛片| 成人特级av手机在线观看| 国产精品电影一区二区三区| 国产亚洲欧美98| 亚洲精品一区av在线观看| 热99re8久久精品国产| 日韩欧美 国产精品| 真人一进一出gif抽搐免费| 成年女人看的毛片在线观看| 午夜精品久久久久久毛片777| 成年女人看的毛片在线观看| 好男人在线观看高清免费视频| 18禁美女被吸乳视频| 窝窝影院91人妻| 麻豆国产97在线/欧美| 脱女人内裤的视频| 国产一区二区激情短视频| 国产1区2区3区精品| 亚洲精品粉嫩美女一区| 人人妻人人看人人澡| 亚洲av电影在线进入| 久久精品国产综合久久久| av在线天堂中文字幕| 国产伦在线观看视频一区| 听说在线观看完整版免费高清| 亚洲av成人一区二区三| 黄频高清免费视频| 一个人看的www免费观看视频| 久久天躁狠狠躁夜夜2o2o| 小说图片视频综合网站| 精品欧美国产一区二区三| 两个人的视频大全免费| 黄色片一级片一级黄色片| 国产精品影院久久| 亚洲第一欧美日韩一区二区三区| av欧美777| 99久久综合精品五月天人人| 黄色女人牲交| 亚洲在线自拍视频| 久久久久久国产a免费观看| 久久久久久久久中文| 黄色视频,在线免费观看| 国产成+人综合+亚洲专区| 熟女少妇亚洲综合色aaa.| 一a级毛片在线观看| 成年女人毛片免费观看观看9| 啦啦啦免费观看视频1| 精品99又大又爽又粗少妇毛片 | 成人欧美大片| 最近视频中文字幕2019在线8| 国产成+人综合+亚洲专区| 亚洲欧美一区二区三区黑人| 免费无遮挡裸体视频| 免费人成视频x8x8入口观看| 亚洲人成网站在线播放欧美日韩| 欧美乱妇无乱码| 午夜视频精品福利| 国产亚洲欧美98| 精华霜和精华液先用哪个| 老司机福利观看| 国产蜜桃级精品一区二区三区| 精品国产乱子伦一区二区三区| 国语自产精品视频在线第100页| 99热精品在线国产| 亚洲av成人精品一区久久| 日本免费一区二区三区高清不卡| 在线免费观看的www视频| 非洲黑人性xxxx精品又粗又长| 成人特级黄色片久久久久久久| 综合色av麻豆| 久久热在线av| 波多野结衣高清无吗| av视频在线观看入口| 欧美精品啪啪一区二区三区| 淫秽高清视频在线观看| 国产高清videossex| 少妇人妻一区二区三区视频| а√天堂www在线а√下载| 亚洲精品中文字幕一二三四区| 欧美中文综合在线视频| www日本在线高清视频| 免费av毛片视频| 欧美中文日本在线观看视频| 国产黄片美女视频| 男女视频在线观看网站免费| 亚洲午夜精品一区,二区,三区| 成人午夜高清在线视频| 久久久久免费精品人妻一区二区| 色综合站精品国产| 人妻丰满熟妇av一区二区三区| 美女黄网站色视频| 熟女少妇亚洲综合色aaa.| 成人av在线播放网站| 精品乱码久久久久久99久播| 亚洲午夜精品一区,二区,三区| 亚洲av成人不卡在线观看播放网| 久久中文字幕一级| 一卡2卡三卡四卡精品乱码亚洲| 韩国av一区二区三区四区| 亚洲av成人不卡在线观看播放网| 成年女人永久免费观看视频| 好男人在线观看高清免费视频| 成人欧美大片| 精品国产美女av久久久久小说| 久久久久性生活片| av福利片在线观看| 国产一区二区激情短视频| 人妻久久中文字幕网| 国产一级毛片七仙女欲春2| 久久中文字幕一级| 亚洲精品乱码久久久v下载方式 | 国产精品电影一区二区三区| 亚洲中文av在线| 在线观看舔阴道视频| 91久久精品国产一区二区成人 | 老汉色∧v一级毛片| 亚洲欧美激情综合另类| 久久精品aⅴ一区二区三区四区| 久久午夜综合久久蜜桃| 久久香蕉国产精品| 亚洲最大成人中文| 高清毛片免费观看视频网站| 国产精品久久久久久亚洲av鲁大| 亚洲avbb在线观看| 88av欧美| 一本综合久久免费| a在线观看视频网站| 999久久久国产精品视频| 日本黄色片子视频| 欧美午夜高清在线| 看片在线看免费视频| 免费观看人在逋| 小说图片视频综合网站| 国产成人一区二区三区免费视频网站| 色噜噜av男人的天堂激情| 精品久久久久久久久久免费视频| 黄色视频,在线免费观看| 一个人看的www免费观看视频| 麻豆国产av国片精品| 女人高潮潮喷娇喘18禁视频| 国产av一区在线观看免费| 国产精品九九99| 在线十欧美十亚洲十日本专区| 最近最新免费中文字幕在线| 老汉色∧v一级毛片| 女人被狂操c到高潮| 国产精品一及| 色综合婷婷激情| 男女视频在线观看网站免费| 黄色 视频免费看| 少妇的丰满在线观看| 国产精品久久久久久精品电影| 国产激情偷乱视频一区二区| 欧美成人性av电影在线观看| 久久精品91蜜桃| 女警被强在线播放| 精华霜和精华液先用哪个| 久久国产精品人妻蜜桃| 欧美日韩中文字幕国产精品一区二区三区| 激情在线观看视频在线高清| 精品一区二区三区视频在线 | 国产精品自产拍在线观看55亚洲| 国产乱人伦免费视频| 99精品久久久久人妻精品| 精品人妻1区二区| 欧美国产日韩亚洲一区| 亚洲国产欧美人成| 欧美不卡视频在线免费观看| 欧美日韩一级在线毛片| 国产成人系列免费观看| 亚洲avbb在线观看| 国产亚洲欧美在线一区二区| 一个人看的www免费观看视频| 可以在线观看的亚洲视频| 男女下面进入的视频免费午夜| 久久久久久久久免费视频了| 我要搜黄色片| 久久精品91蜜桃| 国产亚洲欧美98| 黄片小视频在线播放| 国产伦在线观看视频一区| 亚洲精品久久国产高清桃花| 亚洲真实伦在线观看| 欧美大码av| 噜噜噜噜噜久久久久久91| 精品不卡国产一区二区三区| 在线看三级毛片| 热99在线观看视频| 久久久久久久久中文| 中国美女看黄片| 97碰自拍视频| 国产人伦9x9x在线观看| 久久中文字幕一级| 国产一级毛片七仙女欲春2| 久久草成人影院| 99精品欧美一区二区三区四区| 国产午夜精品论理片| 亚洲成av人片免费观看| 五月伊人婷婷丁香| 免费观看精品视频网站| 亚洲黑人精品在线| 日韩免费av在线播放| 国产精品 欧美亚洲| or卡值多少钱| 午夜两性在线视频| www国产在线视频色| 亚洲18禁久久av| 国内精品一区二区在线观看| 在线观看日韩欧美| 99久久精品热视频| 欧美乱码精品一区二区三区| 18禁裸乳无遮挡免费网站照片| av天堂在线播放| 日本一本二区三区精品| av视频在线观看入口| 日韩人妻高清精品专区| 国产高清videossex| 国内毛片毛片毛片毛片毛片| 身体一侧抽搐| 法律面前人人平等表现在哪些方面| 淫秽高清视频在线观看| 日本黄色视频三级网站网址| 欧美丝袜亚洲另类 | 午夜日韩欧美国产| 男插女下体视频免费在线播放| 91av网一区二区| 日日摸夜夜添夜夜添小说| 久久亚洲真实| 国产av在哪里看| 久久热在线av| 国产成人精品无人区| 国产精品综合久久久久久久免费| 亚洲精品乱码久久久v下载方式 | 国产精品亚洲av一区麻豆| 国产av不卡久久| 亚洲欧美精品综合一区二区三区| 国产视频内射| АⅤ资源中文在线天堂| 国产精品99久久99久久久不卡| xxxwww97欧美| 亚洲熟妇中文字幕五十中出| 国语自产精品视频在线第100页| 97超级碰碰碰精品色视频在线观看| 男女床上黄色一级片免费看| 欧美不卡视频在线免费观看| aaaaa片日本免费| 波多野结衣高清作品| 一个人看的www免费观看视频| 97超级碰碰碰精品色视频在线观看| 国产高清视频在线观看网站| 亚洲av五月六月丁香网| 99热6这里只有精品| 精品乱码久久久久久99久播| 婷婷亚洲欧美| 两人在一起打扑克的视频| 国产av不卡久久| 女同久久另类99精品国产91| 老司机午夜福利在线观看视频|